Huangqin Qingre Chubi Capsule inhibits rheumatoid arthritis by regulating intestinal flora and improving intestinal barrier
Frontiers in Pharmacology · 26.06.2024 · 15
DOI: 10.3389/fphar.2024.1422245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.06.2024. Verfasst von Yanhui Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Changes in intestinal flora and intestinal barrier in patients with preclinical and diagnosed rheumatoid arthritis (RA) suggest that intestinal flora and intestinal barrier play an important role in the induction and persistence of RA. Huangqin Qingre Chubi Capsule (HQC) is a clinically effective herbal formula for the treatment of RA, but its therapeutic mechanism has not been fully clarified. Materials and methods In this study, real-time qPCR (RT-qPCR), 16SrRNA sequencing, Western blot (WB), immunofluorescence and other methods were used to investigate whether HQC inhibited RA.
Results
Based on research in collages-induced arthritis (CIA) model in mice, human colon cancer cell line (Caco-2), and fibroblast-like synoviocytes (FLS) from RA patients, we found that intestinal flora was disturbed in CIA model group, intestinal barrier was damaged, and lipolyaccharide (LPS) level was increased, and HQC could regulate intestinal flora and intestinal barrier and reduce LPS translocation into blood. Antibiotic depletion weakened the anti-RA effect of HQC, and HQC fecal microbiota transplantation alleviated RA pathology. In addition, LPS increased the expression of RA pathologic factors MMP3, Fibronectin and inflammatory factors IL-6, TNF-α, IL-1β and IL-8, indicating that elevated peripheral blood level of LPS was related to RA pathology.
Conclusion
The dysregulation of intestinal flora and the disruption of intestinal barrier are significant factors in the development of RA. HQC improves RA by regulating intestinal flora, intestinal barrier and inhibiting LPS translocation into blood. The study unveiles RA’s new pathogenesis and laid a scientific groundwork for advancing HQC therapy for RA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, United States.
- Department of Clinical Nursing, School of Nursing, Anhui University of Chinese Medicine, Hefei, China.
- Department of Orthopaedics, The First Affiliated Hospital, Anhui Public Health Clinical Center, Anhui Medical University, Hefei, China.
- Institute of Prevention and Treatment of Rheumatoid Arthritis, Anhui University of Chinese Medicine, Hefei, Anhui, China.
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hefei, China.
Zitieren
APA
Peng, Y., Huang, Y., Li, H., Li, C., Wu, Y., Chen, Z. S., Wang, X., Liao, F., & Miao, C. (2024). Huangqin Qingre Chubi Capsule inhibits rheumatoid arthritis by regulating intestinal flora and improving intestinal barrier. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1422245
Vancouver
Peng Y, Huang Y, Li H, Li C, Wu Y, Chen ZS, et al. Huangqin Qingre Chubi Capsule inhibits rheumatoid arthritis by regulating intestinal flora and improving intestinal barrier. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1422245
BibTeX
@article{Peng2024,
author = {Peng, Yanhui and Huang, Yurong and Li, Hui and Li, Chen and Wu, Yajie and Chen, Zhe-Sheng and Wang, Xiao and Liao, Faxue and Miao, Chenggui},
title = {Huangqin Qingre Chubi Capsule inhibits rheumatoid arthritis by regulating intestinal flora and improving intestinal barrier},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1422245}
}
EUVIMED